Let’s Get Together

The biosimilars movement is a community dedicated to building a healthier tomorrow. Let’s come together to share ideas and resources to help increase patient access to biosimilars today.

Events for Everyone

Biosimilar medicines have the power to help patients treat serious diseases at a fraction of the cost of brand-name biologics. To raise awareness of biosimilars and bring down barriers, biosimilar advocates, scientists, patients and government officials must join together to find solutions.

The Association for Accessible Medicines (AAM) and its Biosimilars Council are proud to host events to promote biosimilars, and are equally proud to participate in events that others hold. Scroll down to see events that you can participate in to help biosimilar reach their full potential.

October 2-4, 2023 | North Bethesda, MD

GRx+Biosims is the premier scientific and regulatory event for the biosimilars and generics industry. Top officials and subject-matter experts share their knowledge and best practices to enhance attendees’ understanding of how to succeed in generic and biosimilar development, regulatory process and approvals, and the evolving policy landscape.

October 25, 2023 | Hotel Porta Fira, Barcelona, Spain

Join us for the 10th anniversary of the Global Generics and Biosimilars Awards, celebrating the greatest achievements and innovations across the development, authorization, marketing and distribution of global off-patent pharmaceuticals. Winners will be recognized across 14 categories, including Biosimilar Initiative of the Year, Leader of the Year, API Supplier of the Year and new for 2023, Campaign of the Year. The Awards are free to enter! The closing date for entries is Monday, September 4, 2023 and the winners will be revealed at the ceremony on Wednesday, October 25, 2023.

February 5-7, 2024 | Tampa, Florida

Access! is the Association for Accessible Medicines’ annual conference bringing together the top minds in the generic and biosimilars industry. In a multi-day event, you can hear from industry leaders and government representatives about the state of the industry, network with your peers, feature your company at the expo and more.

GRx+Biosims Conference 

November 7-9
North Bethesda, MD

GRx+Biosims is the premier scientific and regulatory event for the biosimilars and generics industry. Join us in person in North Bethesda, MD to hear from leading industry and government representatives, share your ideas and help build the biosimilars movement.

Other Events

IGBA Global Biosimilars Week

  • Each year, the Biosimilars Council invites biosimilars advocates from around the world to share their resources and stories on social media.

Women in Health Policy

  • AAM and the Biosimilars Council regularly host events featuring leading women specializing in health policy and biosimilar medicines. Join the LinkedIn Group for updates.

Related News and Blogs

Blog – Access! 2023 – Takeaways for the Biosimilars Industry

AAM’s annual conference, Access!, was held February 13-15 in Orlando, Florida, where Biosimilars Council members were joined by leaders from... Read more »
People at GRx+Biosims

GRx+Biosims 2022 Conference Recap

Earlier this month, AAM and the Biosimilars Council hosted guests in North Bethesda, Maryland for the 2022 GRx+Biosims Conference. This... Read more »

Access! 2022 Conference Recap

February 14-16, AAM and its Biosimilars Council welcomed attendees to Orlando, Florida for Access! 2022, the generics and biosimilars industry’s... Read more »

GRx+Biosims 2021 Conference Recap

AAM’s 2021 GRx+Biosims conference has officially come to a close, and by all accounts it delivered on its promise to... Read more »
grx+biosims 2020

GRx+Biosims 2020 Conference Wrap-Up Blog

We’ve just completed this year’s GRx+Biosims 2020, the premier scientific and regulatory event for the U.S. generics and biosimilars industries,... Read more »

GRx+Biosims 2019 Conference: Advancing Biosimilars Access

Earlier this month the Association for Accessible Medicines (AAM) and its Biosimilars Council hosted the second annual GRx+Biosims Conference for... Read more »
GRx+Biosims 2019

Biosimilars Council Kicks Off GRx+Biosims 2019

The Association for Accessible Medicines (AAM) and its Biosimilars Council are eager for the start of this year’s GRx+Biosims conference... Read more »
Biosimilars Council - Renegotiated NAFTA Event

Patient Access to Affordable Medicines: How a Renegotiated NAFTA Could Keep Drug Prices High

Friday, September 14, 2018 Noon–1:00 p.m. 1310 Longworth House Office Building Committee on House Administration Hearing Room On August 31,... Read more »
The Biosimilars Council - Seniors Sitting at a Meeting

Breaking Through on Biosimilars: Delivering More-Affordable, Innovative Medicines for America’s Patients

Please join us on Thursday, July 26th at noon for a lunch briefing hosted by the Association for Accessible Medicines (AAM)... Read more »
The Biosimilars Council - GRxBiosims Event Banner

GRx+Biosims Conference

AAM listened to our members and conference attendees and has created the ultimate event for the industry. We combined all... Read more »
The Biosimilars Council - People Meeting Image

AAM Women in Health Policy Happy Hour

Thursday, April 19, 2018 – 5-7pm – 601 New Jersey Ave. NW Join The Biosimilars Council and the Association for... Read more »
The Biosimilars Council - Doctors Applauding

Leading on Biosimilars: 2017 AAM Biosimilars Council Conference Preview

Join us as we examine the promise of biosimilars in the United States and discuss how best to ensure patient... Read more »

The Next Drugs: An Atlantic Policy Briefing on Biosimilars

Underwritten by The Biosimilars Council The Atlantic gathered key stakeholders to examine the emerging world of biosimilars and their regulatory framework in the United States. How does the Food and Drug Administration implement[…]

The Next Drugs: The Future for Biosimilars, An Atlantic Policy Briefing

Join The Atlantic as we gather key stakeholders to examine the future for biosimilars domestically and abroad. What impact will... Read more »